slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 4,261-4,290
Pages 1,371
Rows per page 30
Component
4,261-4,290 of 41,127
01
2022 Manufacturing Survey2022 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
06
The chart is split into two categories: 'More focus in near-term' (Material cost & inflation, Supply chain disruption, Labor shortages) and 'Less focus in near-term' (Electrification, Automation, Sustainability/ESG, Digital & AI).2022 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Aha Moment1 hit
07
The table uses icons to represent priorities and arrows to indicate rank shifts of 3+ positions.2022 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Aha Moment1 hit
01
2023 Manufacturing Survey2023 Manufacturing Survey · L.E.K.
Consulting deck Strategy consulting 1 hit
08
The slide uses stacked bar charts to visualize survey data regarding hospital financial performance.APAC Hospital Insights 2023 · LEK
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Aha Moment1 hit
09
The slide uses stacked bar charts to visualize survey data regarding hospital financial performance.APAC Hospital Insights 2023 · LEK
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Aha Moment1 hit
11
Includes a legend for trend indicators (arrows) and color-coding for top 2 performers.APAC Hospital Insights 2023 · LEK
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Aha Moment1 hit
12
The chart uses a stacked bar format to show sentiment distribution across 7 regions/countries.APAC Hospital Insights 2023 · LEK
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Aha Moment1 hit
19
The chart includes indicators for ranking changes from the 2022 survey.APAC Hospital Insights 2023 · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
22
The slide uses a stacked bar chart format to represent survey data on digital adoption, including a comparative indicator against China and India.APAC Hospital Insights 2023 · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
08
The slide uses a stacked bar chart to show sector composition by country, with a total aggregate bar on the right.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Loop · Pattern Hunter1 hit
27
The chart highlights a shift in sector focus for M&A activity in Colombia over a decade.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
28
The chart shows a clear decline in total deal volume over the decade, with a shift in investor composition.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
01
Perspectives on US Healthcare Inflation Insights from L.E.K. ConsultingPerspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
The chart uses a dual-line plot to show the divergence between healthcare and general inflation, with a shaded region for the Great Recession.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Mece Breakdown1 hit
06
The slide uses a dual-axis chart combining line graphs for cumulative change and bar charts for 12-month percentage change.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
01
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
09
The slide uses stacked bar charts to show the composition of clinical trials by phase (I, II, III) for China and the US.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit
12
The slide combines quantitative survey data (N=101) with qualitative expert quotes to contextualize the market sentiment.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
16
The chart uses a broken y-axis to accommodate the large number of companies in the 1-5 project range.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
20
The slide uses a stacked bar chart to show survey responses and a callout box for qualitative expert feedback.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
24
The chart shows a clear shift in clinical trial focus toward oncology, increasing from 30% in 2016 to 48% in 2022.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
26
The chart highlights factors directly related to commercial attractiveness in green.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
27
The chart uses a 7-point Likert scale. The top 4 categories are highlighted in green.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
37
The slide uses a visual bridge to connect the 'Likely'/'Highly Likely' and 'Unlikely'/'Not Possible' segments of the survey to their respective rationales.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
41
The slide uses stacked bar charts to show ranking preferences (Top 1, 2, 3) for destinations and simple bar charts for decision factors.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
58
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting 1 hit
09
Steering Clear of the IT Danger ZonesSteering Clear of the IT Danger Zones · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit
01
RAS likely stands for Robotic Assisted Surgery given the image of a surgical robot.What is and how to navigate the RAS opportunity in LatAm? · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
12
The chart uses a grid-based timeline to represent months, with color-coded bars indicating current approval times and potential reduction intervals.What is and how to navigate the RAS opportunity in LatAm? · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next Steps1 hit